Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

33.71 -0.60 (-1.75%)
Streaming Delayed Price Updated: 1:11 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 87,030
Open 34.29
Bid (Size) 33.66 (100)
Ask (Size) 33.76 (100)
Prev. Close 34.31
Today's Range 33.60 - 34.47
52wk Range 25.86 - 50.79
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not... 
Via StockStory

Performance

YTD
-26.0%
-26.0%
1 Month
-3.0%
-3.0%
3 Month
-29.3%
-29.3%
6 Month
-3.3%
-3.3%
1 Year
+25.3%
+25.3%

More News

Read More
News headline image
1 Value Stock on Our Buy List and 2 Facing Headwinds
Via StockStory
Topics ETFs
News headline image
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Stocks World Trade
Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗
Via Chartmill
Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Q4 Revenue Growth but Misses Earnings Estimates ↗
Via Chartmill
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) Presents a Classic Value Case with High Earnings and Low Valuation ↗
Via Chartmill
News headline image
2 Profitable Stocks to Consider Right Now and 1 We Question
Via StockStory
Topics Bonds
News headline image
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
3 Healthcare Stocks Walking a Fine Line
Via StockStory
News headline image
Collegium to Present New Real-World Data at PainConnect 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today
Via StockStory
News headline image
Collegium (COLL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Via StockStory
News headline image
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect
Via StockStory
Topics World Trade
News headline image
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
1 Profitable Stock on Our Watchlist and 2 That Underwhelm
Via StockStory

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 33.71
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 04/21/26 01:11 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.09B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.